Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Study of Alloknesia in Atopic Dermatitis
A clinical trial sponsored by University Hospital, Brest is investigating Alloknesia in patients with atopic dermatitis and is currently rec…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Double-blind, Randomized, Non-inferiority Trial in Atopic Dermatitis: Comparison of Lipikar Balm and Relipid+ Balm in the Treatment of Mild to Moderate Atopic Dermatitis in Children and Adults [NA]
This clinical trial update describes a double-blind, randomized non-inferiority study comparing Lipikar Balm and Relipid+ Balm for mild-to-m…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis [Phase 3]
This is a Phase 3 clinical trial evaluating Lebrikizumab in children aged 6 months to under 18 years with moderate-to-severe atopic dermatit…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants [Phase 1]
A Phase 1 study evaluated the bioavailability of Rocatinlimab administered via autoinjector and vial in healthy participants. Sponsored by A…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Utilization of a Microdevice for Psoriasis and Atopic Dermatitis [Phase 4]
This clinical trial update describes a Phase 4 study evaluating a microdevice for psoriasis and atopic dermatitis, with recruitment not yet …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) [Phase 3]
Phase 3 trial completion update for Rocatinlimab (AMG 451) in adolescent patients with moderate-to-severe Atopic Dermatitis.
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: A Study to Evaluate Microneedle-based Collection of Dermal Interstitial Skin Fluid in Healthy Participants and Atopic Dermatitis Participants
A clinical trial evaluating microneedle-based collection of dermal interstitial fluid in healthy volunteers and patients with atopic dermati…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic Dermatitis [Phase 3]
A Phase 3 clinical trial evaluating 611, a recombinant anti-IL-4 receptor alpha monoclonal antibody, in Chinese adults with moderate-to-seve…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis [Phase 3]
Pfizer completed a Phase 3 trial evaluating PF-04965842, with or without topical medications, for moderate to severe atopic dermatitis in pa…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice
The LANDSCAPE study, sponsored by Fondazione ISIDE, investigates demographics and treatment patterns of patients with immune-mediated inflam…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase II clinical trial evaluating QLS12010 capsules in adults with moderate-to-severe atopic dermatitis is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of LNK01004 Ointment in Adults With Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of LNK01004 Ointment in adults with Atopic Dermatitis has completed. The study i…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Methotrexat to Hand Eczema in the BIOSKIN Cohort
The BIOSKIN cohort is evaluating methotrexate for hand eczema in patients with atopic dermatitis and contact dermatitis, with the study curr…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Probiotic on Atopic Dermatitis in Infant [NA]
A completed clinical trial sponsored by Glac Biotech evaluated a probiotic for atopic dermatitis in infants.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic Dermatitis [NA]
A clinical trial investigates whether retaining vernix caseosa in newborns could help prevent atopic dermatitis, and the study status is not…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Exploratory Clinical Investigation on Neurosensory Responses Via EEG Headband in Adults With Mild to Moderate Atopic Dermatitis After Application of Marketed Product Compared With Placebo (Water Application). [NA]
An exploratory clinical investigation using an EEG headband to assess neurosensory responses in adults with mild to moderate atopic dermatit…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participants [Phase 1]
Phase 1 study evaluating Rocatinlimab (AMG-451) in healthy Chinese participants has completed, with Atopic Dermatitis identified as the cond…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Comparison Between Topical N-acetyl Cysteine (NAC) in Cold Cream Versus Cold Cream in Mild and Moderate Atopic Dermatitis: Clinical and Bacteriological Evaluation. A Randomized Control Trial. [NA]
A completed randomized controlled trial evaluated topical N-acetylcysteine in cold cream versus cold cream alone for mild to moderate atopic…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy [Phase 3]
Phase 3 trial evaluating tralokinumab for moderate-to-severe atopic hand eczema has completed. The study, sponsored by LEO Pharma, aimed to …
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis [NA]
This is a clinical trial update for a birth-cohort study examining the development of IgE autoantibodies in newborns at high risk of Atopic …
-
CLINICAL_TRIALS other · 2026-01-05Clinical Trial Update: A Phase III Study of Jaktinib in Adults With Moderate and Severe Atopic Dermatitis [Phase 3]
Administrative update on a Phase III trial of jaktinib for adults with atopic dermatitis; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial [Phase 4]
A Phase 4 open-label trial evaluated dupilumab in adolescent and adult participants with moderate-to-severe atopic dermatitis in skin of col…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: A Study for HSK44459 in Participants With Atopic Dermatitis [Phase 2]
This clinical trial update describes a Phase 2 study of HSK44459 for atopic dermatitis, with the trial currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating the efficacy and safety of SCD-044 in moderate-to-severe atopic dermatitis has completed, with results posted.
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of oral roflumilast for moderate to severe atopic dermatitis in patients aged 12…